Jazz Pharmaceuticals (JAZZ)Director filed to sell ~$3.36M

~$3.36M

planned to sell · 15K shares, around Oct 8, 2026

Planned for

Oct 8, 2026

Notice filed

Oct 8, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Aug 10, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
2. Aug 26, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations (and 2 more items)
3. Aug 27, 2026Insider · 1 personInsiders: 6 sales (~$19.2M)
4. Sep 1, 2026InsiderDirector sold ~$1.5M of JAZZ shares in the open market
5. Sep 8, 2026InsiderCEO sold ~$486K of JAZZ shares in the open market
6. Sep 10, 2026InsiderOfficer sold ~$289K of JAZZ shares in the open market
7. Sep 23, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
8. Oct 1, 2026InsiderDirector sold ~$1.38M of JAZZ shares in the open market
9. Oct 6, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On October 6, 2026, Samantha Pearce, Executive Vice President, Chief Commercial Officer of Jazz Pharmaceuticals plc (the “Company” ), notified the Company of her intent to retire from her role as Chief Commercial Officer upon the earlier of the selection and appointment of her successor or by June 30, 2027.”
10. Oct 6, 2026InsiderCEO sold ~$473K of JAZZ shares in the open market

How to read SEC Form 144

Form 144 is a notice that a company insider plans to sell shares. It is filed when the sell order is placed, so it announces a planned sale and does not prove that the sale took place.

Full guide: What is an SEC Form 144?

What else is on file for Jazz Pharmaceuticals

For Jazz Pharmaceuticals, OQRO holds 14 insider filings (SEC Form 4 or Form 144) and 10 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its JAZZ page.

How this filing works

• SEC Form 144
• Rule 10b5-1 trading plans

Other disclosures at Jazz Pharmaceuticals

• SEC Form 4Oct 7, 2026
• SEC Form 4Oct 6, 2026
• SEC Form 144Oct 6, 2026
• SEC Form 4Sep 15, 2026
• SEC Form 4Sep 11, 2026
• SEC Form 4Sep 3, 2026

Everything OQRO holds on this company is on its JAZZ page.